Hematology NewsWomen hematologists advance MM research, give backJune 15, 2023Multiple MyelomaCellular TherapyDiversity in Medicine
Oncology PracticeNumber of cancer survivors with functional limitations doubled in 20 yearsMay 11, 2023Patient & Survivor CareLung CancerDiversity in MedicineBreast CancerMixed TopicsLymphoma & Plasma Cell DisordersLeukemia, Myelodysplasia, Transplantation
Hematology NewsExperts debate reducing ASCT for multiple myelomaMay 3, 2023Multiple MyelomaTransplant
Hematology NewsAFib risk with cancer drugs underestimatedApril 12, 2023Breast CancerLeukemia, Myelodysplasia, TransplantationLung CancerLymphoma & Plasma Cell DisordersImmuno-oncologyHodgkin LymphomaAML
Hematology NewsErythema extent predicts death in cutaneous GVHDMarch 13, 2023TransplantMixed TopicsMultiple MyelomaCLLB Cell LymphomaMantle Cell Lymphoma
Hematology NewsFDA calls for withdrawal of multiple myeloma drug PepaxtoDecember 21, 2022Multiple MyelomaLymphoma & Plasma Cell Disorders
Oncology PracticeMultiple myeloma diagnosed more via emergency care during COVIDDecember 19, 2022Multiple MyelomaLymphoma & Plasma Cell DisordersPreventive CareCOVID-19 Updates
Hematology NewsBlenrep for multiple myeloma withdrawn from U.S. marketNovember 22, 2022Multiple MyelomaBusiness of Medicine
Hematology NewsFDA OKs teclistamab for relapsed/refractory multiple myelomaOctober 25, 2022Multiple Myeloma
Hematology NewsCAR T-cell therapy neurotoxicity linked to NfL elevationsOctober 3, 2022Cellular TherapyAggressive LymphomasALLB Cell LymphomaMultiple MyelomaMixed TopicsCLL
